Skip to content

Case study

Health Economics

Summary Swansea University

An independent evaluation by Swansea University (May 2024) confirms that Clinical Design Technologies’ Automated Urine Testing System (UTS) provides clear and significant economic and operational advantages over traditional dipstick testing.

Despite higher consumable costs, UTS It delivers a 20.5% productivity increase, a Benefit-Cost Ratio of 2.17, and a Return on Investment (ROI) of 117%, with a payback period of less than one year.

By eliminating manual data entry, reducing test errors, and minimising waste, UTS not only lowers operational costs but also enhances patient safety and workflow efficiency. Its adoption unlocks long-term financial savings, improves compliance with quality standards, and strengthens clinical outcomes, offering a compelling case for healthcare organisations seeking to modernise and optimise diagnostic services.